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Abstract Significant paravalvular leakage (PVL) after
transcatheter aortic valve implantation (TAVI) is related to
patient mortality. Predicting the development of PVL has
focused on computed tomography (CT) derived variables
but literature targeting CoreValve devices is limited, con-
troversial, and did not make use of standardized echocar-
diographic methods. The study included 164 consecutive
patients with severe aortic stenosis that underwent TAVI
with a Medtronic CoreValve system, with available pre-
TAVI CT and pre-discharge transthoracic echocardiogra-
phy. The predictive value for significant PVL of the CT-
derived Agatston score, aortic annulus size and eccentric-
ity, and ‘‘cover index’’ was assessed, according to both
echocardiographic Valve Academic Research Consortium
(VARC) criteria and angiographic Sellers criteria. Uni-
variate predictors for more than mild PVL were the max-
imal diameter of the aortic annulus size (for both
angiographic and echocardiographic assessment of PVL),
cover index (for echocardiographic assessment of PVL
only), and Agatston score (for both angiographic and
echocardiographic assessment of PVL). The aortic annulus
eccentricity index was not predicting PVL. At multivariate
analysis, Agatston score was the only independent predic-
tor for both angiographic and echocardiographic assess-
ment of PVL. Agatston score is the only independent
predictor of PVL regardless of the used imaging technique
for the definition of PVL.
Keywords Aortic valve  Transcatheter  Computed
tomography  Echocardiography  Paravalvular leakage 
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Introduction
Paravalvular aortic leakage (PVL) after transcatheter aortic
valve implantation (TAVI) is a complication with poten-
tially severe consequences [1–6]. The main focus in pre-
dicting the development of PVL has been on computed
tomography (CT) derived variables such as calcium
quantification with the Agatston score, aortic annulus size
and eccentricity, and indexes relating the annulus dimen-
sions to prosthesis size like the ‘‘cover index’’ [3]. How-
ever, prediction of PVL may be different for the various
percutaneous valves, since the CoreValve Revalving Sys-
tem is self-expandable while the Edwards SAPIENTM
prosthesis is a balloon-expandable one. In particular, in a
self-expandable prosthesis, calcified native valves may
pose resistance to deployment, resulting in an ellipsoid-
shaped stent and a higher incidence of PVL. Indeed,
Agatston score was predictive for PVL in all published
CoreValve specific studies [7–9]. However, literature
focusing on CoreValve devices and other CT-derived
predictors is limited and reported results are discrepant.
The value of aortic annulus eccentricity was investigated in
only one small study [10] and aortic annulus size or the
‘‘cover index’’ was only analyzed in two relatively small
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CoreValve studies with conflicting results [10, 11]. One of
the reasons for these discrepancies may be the different
methods of defining the PVL end-point: by angiography
[10] versus pre-discharge transthoracic echocardiography
[11]. Also, echocardiographic assessment of PVL was not
performed according to the recently updated Valve Aca-
demic Research Consortium (VARC-2) criteria [12]. The
current study sought to assess, in the thus far largest pub-
lished single-center consecutive CoreValve series, the
univariate and multivariate predictive value of CT-derived
Agatston score, aortic annulus size and eccentricity, and
‘‘cover index’’ for significant PVL. PVL was defined
according to both echocardiographic VARC-2 criteria (also
for the first time defined as a continuous variable rather
than a categorical variable) and angiographic Sellers
criteria.
Methods
Patients
The study included 164 consecutive patients with severe
aortic stenosis that underwent TAVI with a Medtronic
CoreValve system from June 2006 to November 2012,
with available pre-operative Agatston score and pre-dis-
charge transthoracic echocardiography. The details of the
TAVI implantation procedure are described in full detail
elsewhere [13–15]. The first five patients underwent TAVI
with the second-generation Medtronic CoreValve delivery
system, which is implanted using a 21Fr catheter inserted
into the common femoral (n = 4) or the subclavian
(n = 1) artery using surgical exposure without the use of
an arterial sheath. All other patients underwent TAVI with
the third-generation delivery system, using an 18Fr arterial
sheath inserted into the femoral artery using an echocar-
diographic-guided Seldinger technique and closure with a
10Fr Prostar7 (Prostar XL, Abbott Vascular, IL); except for
four who underwent the subclavian approach. All patients
underwent general anesthesia, and valve implantation was
done using cine and fluoroscopic guidance. The institu-
tional review board approved the study.
CT study
A pre-operative CT scan was performed in all patients
using dual source CT (Somatom Definition, Siemens
Medical Solutions, Forchheim, Germany). A non-contrast
calcification score acquisition was performed before con-
trast MSCT. The pitch was adjusted to fit the heart rate, and
the volume of iodinated contrast material was adapted to
the expected scan time: 50–60 ml of VisipaqueVR
320 mg l/ml, (GE Health Care, Eindhoven, The
Netherlands) were injected in an antecubital vein at a flow
rate of 5.0 ml/s followed by a second contrast bolus of
30–40 at 3.0 ml/s. The scan ranged from the top of the
aortic arch to the diaphragm. 3D reconstructions in end
systole were obtained using a single-segmental algorithm
with slice thickness 1.5 mm and increment 0.4 mm. The
radiation doses ranged from 8 to 20 mSv depending on
body habitus and table speed. The aortic annulus was
defined as a virtual ring with three anchor points at the
bases of the three aortic leaflets [16]; the minimum and
maximum diameters and area of the annulus were mea-
sured in a viewing plane axial to the aortic root to match
that definition [17]. Propriety software was developed to
allow measurement of aortic annulus size on a contrast
MSCT (3mensio Medical Imaging, Bilthoven, the Nether-
lands). A scan without contrast enhancement was available
in 98 of 110 patients because it was initially not performed
in patients with previous CABG or coronary stents. The
non-contrast MSCT acquisition was performed in a
prospectively ECG-triggered, sequential (step-and-shoot)
mode with a reference tube current of 80 mAs, a tube
voltage of 120 kV and slice thickness of 3 mm in the early
or mid diastolic heart phase depending on the heart rate;
the latter data sets were used to derive the Agatstone score
[18]. For analysis on a dedicated cardiovascular CT
workstation (MMWP, Siemens AG, Forchheim, Germany)
the aortic root was defined as the stretching from the caudal
aspect of the aortic annulus to the origin of the left main
stem as seen on axial images [19]. The threshold for the
detection of calcium was set at 130 HU. In cases where
aortic root cal-cification was confluent with calcium in
adjacent structures (mitral annulus, ascending aorta, coro-
nary arteries) only the stack of images that contained the
aortic root were selected.
Angiographic evaluation of paravalvular leakage
Ten minutes after the deployment of the prosthetic valve,
angiography of the aortic root was performed to assess the
severity of aortic regurgitation according to Sellers criteria
[20]. During evaluation of the aortography images the cases
were labeled according to the following criteria: (0) no
regurgitation; (1) only trace of contrast could be seen in the
left ventricle, and it is cleared in each systole; (2) contrast
filling the entire LV in diastole with less density compared
with opacification of the ascending aorta; (3) contrast filling
the entire LV in diastole equal in density to the contrast
opacification of the ascending aorta; and (4) contrast filling
of the entire LV in diastole on the first beat with greater
density compared with the contrast opacification of the
ascending aorta. Two observers independently scored the
images. In case of discrepancy the images were re-evalu-
ated and consensus was reached by a third observer.
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Echocardiographic study
All patients were evaluated after TAVI by pre-discharge
transthoracic echocardiography using an iE33 ultrasound
system (Philips Medical System, Best, the Netherlands)
equipped with a S5-1 transducer. The extent of PVL was
assessed according to the main VARC criterion, that is the
circumferential extent of PVL in a parasternal short-axis
view [12], as seen in Fig. 3. The VARC scores were pro-
vided as continuous values as well as categorical values:
(0) no regurgitation; (1) mild PVL was defined as\10 %
circumferential extent; (2) moderate PVL was defined as
[10 % but\30 % of PVL and (3) severe PVL was defined
as[30 % according to the updated VARC guideline [12].
Significant PVL was defined as a VARC-2 score more than
mild.
Predictors of PVL
Maximal aortic annulus diameter [3] was obtained from the
CT scans using three-dimensional reconstruction performed
with the Siemens Circulation software, in a plane aligned
to cut the lower part of all three the aortic cusps, as
described earlier by us [11]. The Cover Index was defined
as 100 ðnominal prosthesis diameter  CT mean annulus
diameterÞ=nominal prosthesis diameter [21, 22], and the
Eccentricity Index was calculated as 100  ð1 ðaortic
annulusminimum diameter= maximum diameterÞÞ [10]. The
annulus measurements for the latter indices were derived
from the same CT plane described before, and the mean
diameter was calculated as an average between the maximum
and minimum one. The prosthesis nominal diameters used
were provided by the manufacturer. The amount of calcifi-
cation [7–9] was assessed as the Agatston score by the same
CT analysis software in the non-contrast scans, with the
interest zone confined to the segment of the aorta ranging
from the anterior mitral leaflet to the origin of the left
coronary artery.
Statistical analysis
All data gathered were analyzed using SPSS (IBM, version
20). Continuous variables were checked for normal distri-
bution via the Kolmogorov–Smirnov test and were
expressed as mean (±standard deviation), median
(25–75 % percentile), or number (percentage) as appro-
priate. Inter and intraobserver variability was expressed as
correlation as well as weighted kappa for categories. The
predictors were plotted against both the continuous values
of VARC-2 score and the Sellers degree using Spearman
correlation; p values and Spearman’s coefficient (q) are
provided. Because of a lack of homogeneity between the
VARC-2 score, divided in four categories, and the Sellers’
one, that recognizes five categories, the latter was com-
pared with the continuous values of circumferential extent
of the PVL. Each predictor was also tested against signif-
icant (more than mild) paravalvular regurgitation by
Mann–Whitney test. Multivariate analysis was carried on
by linear regression with a stepwise backward method.
Results
Clinical and demographic characteristics
of the population
Of the 164 patients, 87 were male (54 %), and the median
age was 81 (78–85) years. Pre-operative aortic mean
pressure gradient was 43 ± 15 mm Hg, and aortic valve
area was 0.7 ± 0.2 cm2. (Table 1) The Logistic Euroscore
median was 13 (10–21). A 26 mm device was implanted in
42 (26 %) patients, a 29 mm in 113 (69 %) and a 31 mm in
9 (5 %) cases.
Inter and intraobserver variability
in the angiographic and echocardiographic
evaluation
Inter and intraobserver variability in the echocardiographic
evaluation was assessed in a subset of 50 random patients.
The same clips were evaluated by two experienced
echocardiographers to provide an esteem of the interob-
server variability (r = 0,92, p\ 0,05 for continuous val-
ues) and were then re-evaluated in random order after some
Table 1 Clinical characteristics of the study population
Feature Value
Age (years), median (IQR) 81 (78–85)
Male, n (%) 87 (54)
New York Heart Association class CIII, n (%) 132 (81)
Previous cerebrovascular event, n (%) 39 (24)
Previous myocardial infarction, n (%) 39 (24)
Previous coronary artery bypass graft surgery, n (%) 49 (30)
Previous percutaneous coronary intervention, n (%) 44 (27)
Diabetes mellitus, n (%) 43 (27)
Hypertension, n (%) 98 (60)
Peripheral vascular disease, n (%) 19 (12)
Chronic obstructive pulmonary disease, n (%) 43 (27)
Laboratory results
Creatinine (umol/l), median (IQR) 93 (74–118)
Haemoglobin (g/dl), median (IQR) 7.7 (7.1–8.4)
Logistic euroscore, median (IQR) 13 (10–21)
Mean aortic pressure gradient (mmHg), mean ± SD 43 ± 15
Aortic valve area (cm2), mean ± SD 0.7 ± 0.2
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months by one of them to assess intraobserver variability
(r = 0,95, p\ 0,05). Categorical values were also not
statistically different in interobserver variability (weighted
j = 0.86; see Table 2).
Correlation in the Sellers’ score series between the first
and the second observer was acceptable (r = 0,87,
p\ 0.05); cathegorical values are provided for the same
subset of patients selected for the previous analysis
(weighted j = 0.90, see Table 3). To provide a better
evaluation, however, a consensus was obtained from a third
observer in case of disagreement and the resulting scores
were used for further statistical analysis.
Correlation between echocardiographic
and angiographic evaluation of PVL
At echocardiography PVL was not observed in 67 patients
(41 %); it was mild in 44 (27 %), moderate in 44 (27 %),
and severe in 9 (5 %). More than mild PVL was thus
detected in 53 cases (32 %). The median values (25-75
percentiles) in the categories were 4 % (3–8 %) for mild,
16 % (12–21 %) for moderate and 45 % (33–50 %) for
severe PVL (Fig. 1). Following Sellers criteria, the patients
were classified as aortic regurgitation grade 0 in 12 (7 %)
cases, grade 1 in 39 (24 %), grade 2 in 99 (60 %), and
grade 3 in 14 (9 %). No patient had grade 4 aortic regur-
gitation. There was a significant correlation between the
Sellers and VARC score (q = 0.481, p\ 0.001) (Fig. 2).
Correlation between aortic annulus and cover index
There was a significant inverse correlation (q = -0.734,
p\ 0.001) between the maximum aortic annulus diameter
and the cover index.
Table 2 Category correlation for interobserver variability in VARC
score in a subset of 50 random patients: weighted j = 0.86
(0.66–0.93)
Observer 1
Grade 0 ?1 ?2 ?3 Total
Observer 2
0 19 1 0 0 20
?1 0 12 2 0 14
?2 0 2 11 1 14
?3 0 0 1 1 2
Total 19 15 14 2 50
0 = none, 1 = mild, 2 = moderate, 3 = severe
Table 3 Category correlation for interobserver variability in Sellers’
score in a subset of 50 random patients: weighted j = 0.90
(0.74–0.99)
Observer 1
Grade 0 ?1 ?2 ?3 ?4 Total
Observer 2
0 5 0 0 0 0 5
?1 0 11 1 0 0 14
?2 0 2 26 0 0 14
?3 0 0 1 4 0 5
?4 0 0 0 0 0 0
Total 5 13 28 4 0 50
Fig. 1 Distribution of VARC-2 scores according to the VARC-2
categories
Fig. 2 Correlation between angiographic Sellers grading and contin-
uous value of VARC-2 scores for the assessment of paravalvular
leakage
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Predictors of PVL as assessed by angiography
(Sellers)
As seen in Tables 4 and 5, significant predictors for
more than mild PVL assessed by angiography were the
maximal diameter of the aortic annulus size (27.9 ± 2.6
vs. 26.7 ± 2.3 mm, p = 0.006; correlation 0.178, p =
0.005), cover index (12.6 [9.6–15.1] vs. 14.4 [11.8–18.2],
p = 0.007; correlation -0.143, p = 0.019]), and Agat-
ston score (3,346 [2,363–4886] vs. 2123 [1477–2777]
Hounsfield units, p\ 0.001; correlation 0.395, p\
0.001). The eccentricity index was not a predictor for
PVL.
Predictors of PVL as assessed by echocardiography
(VARC-2)
As seen in Tables 4 and 5, significant predictors for
more than mild PVL assessed by echocardiography were
the maximal diameter of the aortic annulus size (28.1 ±
2.4 vs. 27.2 ± 2.5 mm, p = 0.039; correlation 0.210,
p = 0.003), and Agatston score (3952 [2528–5071] vs.
2596 [1782–4034] Hounsfield units, p = 0.001; correla-
tion 0.305, p\ 0.001). Although not a significant pre-
dictor, a weak but significant correlation existed between
the cover index and PVL (correlation -0.134,
p = 0.043). The eccentricity index was not a predictor
for PVL.
Multivariate analysis
At multivariate analysis, the Agatston score was the only
independent predictor for PVL, regardless of the method of
PVL assessment: p = 0.001, b = 0.265 for the echocar-
diographic VARC score and p = 0.004, b = 0.272 for the
angiographic Sellers score (Fig. 3).
Discussion
The main findings of this study are: (1) maximal aortic
annulus diameter and Agatston score predicted more than
mild PVL and correlated to PVL extent regardless of the
used imaging technique to define PVL, (2) cover index
predicted angiographic PVL but did not predict echocar-
diographic PVL, although a weak but significant correla-
tion existed, (3) aortic annulus eccentricity did not predict
PVL, and (4) Agatston score was for both PVL imaging
techniques the only independent predictor for PVL.
The literature about prediction of PVL after implanta-
tion of a CoreValve prosthesis is limited because of the
relatively small number of available CoreValve specific
reports [7, 8, 10, 11, 23, 24], including small number of
patients, conflicting results, assessment of PVL by different
techniques (angiography [10] versus pre-discharge
transthoracic echocardiography [11]), and the use of
echocardiographic methods not recommended by the
VARC [3, 25]. The present study is the largest so far
Table 4 Prediction of aortic paravalvular leakage as assessed by echocardiography (VARC-2) and angiography (Sellers)
Predictor Echocardiographic VARC-2 score Angiographic Sellers score
None or mild
n = 111
More than mild
n = 53
p value None or mild
n = 51
More than mild
n = 113
p value
Maximal annulus diameter,
mm
27.2 ± 2.5 28.1 ± 2.4 0.039 26.7 ± 2.3 27.9 ± 2.6 0.006
Cover index (%) 14.0 (10.3–17.3) 12.6 (8.6–16.4) 0.204 14.4 (11.8–18.2) 12.6 (9.6–15.1) 0.007
Eccentricity index (%) 20.4 ± 6.7 20.9 ± 6.4 0.644 20.5 ± 6.4 20.6 ± 6.7 0.939
Agatston score 2596 (1782–4034) 3952 (2528–5071) 0.001 2123 (1477–2777) 3346 (2363–4886) \0.001
Table 5 Correlations between predictors for aortic paravalvular leakage and actual paravalvular leakage as assessed by echocardiography
(VARC-2) and angiography (Sellers)
Predictor VARC-2 score Angiography score
q value p value q value p value
Maximal annulus diameter 0.210 0.003 0.178 0.005
Cover index –0.134 0.043 –0.143 0.019
Eccentricity index 0.030 0.350 0.036 0.303
Agatston score 0.305 \0.001 0.395 \0.001
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published single-center consecutive CoreValve series
describing prediction of PVL as defined by both angio-
graphic and VARC echocardiography criteria with well-
known parameters as the Agatston score, aortic annulus
size and eccentricity, and the cover index. Also, correla-
tions between predictors and outcome (PVL) parameters
were for the first time based on both continuous variables
and categorical variables.
Aortic annulus calcification measured by Agatston score
was predictive for PVL in all published CoreValve specific
studies [7, 8, 11] and in our study it was the only inde-
pendent predictor of PVL, regardless of its definition by
angiography or echocardiography. The relationship
between aortic annulus calcification and the incidence of
PVL is based on a suboptimal adherence of the prosthesis
to the aortic root walls because of the calcified native
leaflets that, even if crushed by balloon inflation before,
during, or after the procedure, cannot be totally removed.
The powerful Agatston score was recently reported to even
predict cardiovascular events [7].
In addition, lower values of the cover index were
correlated with the severity of PVL, confirming that a
prosthesis that is too small related to the native annulus
can induce PVL. This has already led to a tendency to
oversize the prosthesis [26]. The relationship between the
larger size of the aortic annulus and the incidence of PVL
is probably due to a greater probability of undersizing of
the prosthetic valve; patients with a larger aortic annulus
had indeed lower cover index values. It should also be
noted that only at the final time frame of this study the
largest (31 mm) CoreValve prosthesis size became
available. Although not an independent predictor for PVL
it should be recognised that the cover index is in fact the
only one on which the interventional cardiologist can
actually intervene, since all others are strictly related to
the anatomy of the patient.
The aortic annulus is well known to be eccentric [27]
but the eccentricity index did not predict PVL. Its value
recently already met some criticism [28]. It is known that,
according to CT scans before and after TAVI with balloon-
expandable devices, the aortic annulus becomes more cir-
cular after the prosthesis placement, adapting to its shape
[22, 29, 30]. Therefore, it may be expected that the annular
shape may influence the grade of PVL only to a small
extent. However, the CoreValve prosthesis is self-ex-
pandable and may adapt more to the annulus rather than
vice versa. Our data show that also with the CoreValve
prosthesis aortic annulus eccentricity does not influence the
grade of PVL, although it cannot be excluded that balloon
inflation performed before the implantation in patients with
a significant calcium burden may have influenced this
result.
Fig. 3 Examples from two
patients with low and high
Agatston score, respectively and
corresponding colour Doppler
short-axis views of paravalvular
leak on 2D echocardiography
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Limitations
The Sellers score includes total aortic regurgitation
(transvalvular and paravalvular cannot be separately
assessed) which will always to some extent limit the cor-
relation to an echocardiographic PVL score. However,
transvalvular aortic regurgitation was seen on echocardio-
graphy in a very small amount of patients and was usually
trivial.
Both the Sellers score and the VARC score are highly
subjective. In particular, the echocardiographic VARC one
is not validated and harbours many difficulties such as
underestimation due to poor acoustic windows or an
incorrect (to high) level of image acquisition, or overesti-
mation due to circumferentially flying jets and an incorrect
(to low) level of image acquisition.
Conclusion
The Agatston score is the only independent predictor of
PVL regardless of the used imaging technique for the
definition of PVL.
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